Indications and Outcomes of Patients Undergoing Immediate Sequential Bilateral Vitreoretinal Surgery: A Case Series
Ophthalmologica · 2025
DOI: 10.1159/000546410 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmologica, 2025. Verfasst von Alasdair I Simpson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK. Hauptthemen laut MEDLINE: Vitreoretinal Surgery, Visual Acuity, Retinal Detachment, Vitreous Hemorrhage. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Bilateral vision threatening vitreoretinal disease requiring urgent surgery such as proliferative diabetic retinopathy, vitreous haemorrhage and retinal detachment are not uncommon presentations. Accepted practice has been to address each eye in separate, staged procedures. However, there are specific circumstances in which operating on both eyes in the same anaesthetic sitting may be preferable. Immediate sequential bilateral vitreoretinal surgery (ISBVS) has rarely been described in the literature. We present a series of cases and discuss the indications, risks and relative merits of this approach.
Method
Multicentre retrospective case series of patients undergoing ISBVS. We circulated a proforma to surgeons across the UK to collate a series of cases of this rarely performed approach to collate indications, operative approach and post-operative results.
Results
Seventeen patients (34 eyes) underwent ISBVS from 8 centres. Twenty eyes had rhematogenous retinal detachments, 12 eyes had diabetic vitreous haemorrhage or tractional detachment and 2 had full-thickness macular hole. Principal pathology was the same bilaterally in each case. Indications for bilateral surgery included bilateral disease requiring urgent surgical intervention, high-risk general anaesthetic, anticipated difficulty with follow-up, convenience in post-operative care and patient preference. Visual acuity improved in 22 eyes and worsened in 2. Post-operative complications included four eyes with elevated intraocular pressure, three vitreous haemorrhages, one cystoid macular oedema, and one with a macular fold. One required re-operation for non-clearing vitreous haemorrhage.
Conclusion
ISBVS is a useful approach which may be underutilised, but further studies are required to validate its safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK.
- Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK, anthony.gigon@gmail.com.
- Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
- Royal Devon University Hospitals Healthcare NHS Foundation Trust, Exeter, UK.
- Mid and South Essex NHS Foundation Trust, Southend-on-Sea, UK.
- University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Zitieren
APA
Simpson, A. I., Gigon, A., Whitlow, S., McGowan, G., Burgula, S., Ramsden, C. M., Chandra, A., Keller, J., Davies, A., Hussain, R., Steel, D. H., & Saidkasimova, S. (2025). Indications and Outcomes of Patients Undergoing Immediate Sequential Bilateral Vitreoretinal Surgery: A Case Series. Ophthalmologica. https://doi.org/10.1159/000546410
Vancouver
Simpson AI, Gigon A, Whitlow S, McGowan G, Burgula S, Ramsden CM, et al. Indications and Outcomes of Patients Undergoing Immediate Sequential Bilateral Vitreoretinal Surgery: A Case Series. Ophthalmologica. 2025. doi:10.1159/000546410
BibTeX
@article{Simpson2025,
author = {Simpson, Alasdair I and Gigon, Anthony and Whitlow, Shane and McGowan, Gerard and Burgula, Sree and Ramsden, Conor M and Chandra, Aman and Keller, Johannes and Davies, Andrew and Hussain, Rumana and Steel, David H and Saidkasimova, Shohista},
title = {Indications and Outcomes of Patients Undergoing Immediate Sequential Bilateral Vitreoretinal Surgery: A Case Series},
journal = {Ophthalmologica},
year = {2025},
doi = {10.1159/000546410}
}
EUVIMED